Coordination of peptidoglycan synthesis and outer membrane constriction during Escherichia coli cell division

  1. Andrew N Gray
  2. Alexander J F Egan
  3. Inge L van't Veer
  4. Jolanda Verheul
  5. Alexandre Colavin
  6. Alexandra Koumoutsi
  7. Jacob Biboy
  8. Maarten A F Altelaar
  9. Mirjam J Damen
  10. Kerwyn Casey Huang
  11. Jean-Pierre Simorre
  12. Eefjan Breukink
  13. Tanneke den Blaauwen
  14. Athanasios Typas
  15. Carol A Gross  Is a corresponding author
  16. Waldemar Vollmer
  1. University of California, San Francisco, United States
  2. Newcastle University, United Kingdom
  3. University of Utrecht, Netherlands
  4. University of Amsterdam, Netherlands
  5. Stanford University, United States
  6. European Molecular Biology Laboratory Heidelberg, Germany
  7. Université Grenoble Alpes, France

Abstract

To maintain cellular structure and integrity during division, Gram-negative bacteria must carefully coordinate constriction of a tripartite cell envelope of inner membrane (IM), peptidoglycan (PG) and outer membrane (OM). It has remained enigmatic how this is accomplished. Here, we show that envelope machines facilitating septal PG synthesis (PBP1B-LpoB complex) and OM constriction (Tol system) are physically and functionally coordinated via YbgF, renamed CpoB (Coordinator of PG synthesis and OM constriction, associated with PBP1B). CpoB localizes to the septum concurrent with PBP1B-LpoB and Tol at the onset of constriction, interacts with both complexes, and regulates PBP1B activity in response to Tol energy state. This coordination links PG synthesis with OM invagination and imparts a unique mode of bifunctional PG synthase regulation by selectively modulating PBP1B cross-linking activity. Coordination of the PBP1B and Tol machines by CpoB contributes to effective PBP1B function in vivo and maintenance of cell envelope integrity during division.

Article and author information

Author details

  1. Andrew N Gray

    Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Alexander J F Egan

    Centre for Bacterial Cell Biology, Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle Upon Tyne, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Inge L van't Veer

    Membrane Biochemistry and Biophysics, Bijvoet Centre for Biomolecular Research, University of Utrecht, Utrecht, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  4. Jolanda Verheul

    Bacterial Cell Biology, Swammerdam Institute for Life Sciences, Faculty of Science, University of Amsterdam, Amsterdam, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  5. Alexandre Colavin

    Biophysics Program, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Alexandra Koumoutsi

    Genome Biology Unit, European Molecular Biology Laboratory Heidelberg, Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Jacob Biboy

    Centre for Bacterial Cell Biology, Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle Upon Tyne, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Maarten A F Altelaar

    Biomolecular Mass Spectrometry and Proteomics, Bijvoet Centre for Biomolecular Research, University of Utrecht, Utrecht, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  9. Mirjam J Damen

    Biomolecular Mass Spectrometry and Proteomics, Bijvoet Centre for Biomolecular Research, University of Utrecht, Utrecht, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  10. Kerwyn Casey Huang

    Biophysics Program, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Jean-Pierre Simorre

    Institut de Biologie Structurale, Université Grenoble Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  12. Eefjan Breukink

    Membrane Biochemistry and Biophysics, Bijvoet Centre for Biomolecular Research, University of Utrecht, Utrecht, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  13. Tanneke den Blaauwen

    Bacterial Cell Biology, Swammerdam Institute for Life Sciences, Faculty of Science, University of Amsterdam, Amsterdam, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  14. Athanasios Typas

    Genome Biology Unit, European Molecular Biology Laboratory Heidelberg, Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  15. Carol A Gross

    Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, United States
    For correspondence
    cgrossucsf@gmail.com
    Competing interests
    The authors declare that no competing interests exist.
  16. Waldemar Vollmer

    Centre for Bacterial Cell Biology, Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle Upon Tyne, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.

Copyright

© 2015, Gray et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,900
    views
  • 1,669
    downloads
  • 149
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Andrew N Gray
  2. Alexander J F Egan
  3. Inge L van't Veer
  4. Jolanda Verheul
  5. Alexandre Colavin
  6. Alexandra Koumoutsi
  7. Jacob Biboy
  8. Maarten A F Altelaar
  9. Mirjam J Damen
  10. Kerwyn Casey Huang
  11. Jean-Pierre Simorre
  12. Eefjan Breukink
  13. Tanneke den Blaauwen
  14. Athanasios Typas
  15. Carol A Gross
  16. Waldemar Vollmer
(2015)
Coordination of peptidoglycan synthesis and outer membrane constriction during Escherichia coli cell division
eLife 4:e07118.
https://doi.org/10.7554/eLife.07118

Share this article

https://doi.org/10.7554/eLife.07118

Further reading

    1. Microbiology and Infectious Disease
    Srinivasan Vijay, Nguyen Le Hoai Bao ... Nguyen Thuy Thuong
    Research Article

    Antibiotic tolerance in Mycobacterium tuberculosis reduces bacterial killing, worsens treatment outcomes, and contributes to resistance. We studied rifampicin tolerance in isolates with or without isoniazid resistance (IR). Using a minimum duration of killing assay, we measured rifampicin survival in isoniazid-susceptible (IS, n=119) and resistant (IR, n=84) isolates, correlating tolerance with bacterial growth, rifampicin minimum inhibitory concentrations (MICs), and isoniazid-resistant mutations. Longitudinal IR isolates were analyzed for changes in rifampicin tolerance and genetic variant emergence. The median time for rifampicin to reduce the bacterial population by 90% (MDK90) increased from 1.23 days (IS) and 1.31 days (IR) to 2.55 days (IS) and 1.98 days (IR) over 15–60 days of incubation, indicating fast and slow-growing tolerant sub-populations. A 6 log10-fold survival fraction classified tolerance as low, medium, or high, showing that IR is linked to increased tolerance and faster growth (OR = 2.68 for low vs. medium, OR = 4.42 for low vs. high, p-trend = 0.0003). High tolerance in IR isolates was associated with rifampicin treatment in patients and genetic microvariants. These findings suggest that IR tuberculosis should be assessed for high rifampicin tolerance to optimize treatment and prevent the development of multi-drug-resistant tuberculosis.

    1. Evolutionary Biology
    2. Microbiology and Infectious Disease
    Zachary H Williams, Alvaro Dafonte Imedio ... Welkin E Johnson
    Research Article Updated

    HERV-K(HML-2), the youngest clade of human endogenous retroviruses (HERVs), includes many intact or nearly intact proviruses, but no replication competent HML-2 proviruses have been identified in humans. HML-2-related proviruses are present in other primates, including rhesus macaques, but the extent and timing of HML-2 activity in macaques remains unclear. We have identified 145 HML-2-like proviruses in rhesus macaques, including a clade of young, rhesus-specific insertions. Age estimates, intact open reading frames, and insertional polymorphism of these insertions are consistent with recent or ongoing infectious activity in macaques. 106 of the proviruses form a clade characterized by an ~750 bp sequence between env and the 3′ long terminal repeat (LTR), derived from an ancient recombination with a HERV-K(HML-8)-related virus. This clade is found in Old World monkeys (OWM), but not great apes, suggesting it originated after the ape/OWM split. We identified similar proviruses in white-cheeked gibbons; the gibbon insertions cluster within the OWM recombinant clade, suggesting interspecies transmission from OWM to gibbons. The LTRs of the youngest proviruses have deletions in U3, which disrupt the Rec Response Element (RcRE), required for nuclear export of unspliced viral RNA. We show that the HML-8-derived region functions as a Rec-independent constitutive transport element (CTE), indicating the ancestral Rec–RcRE export system was replaced by a CTE mechanism.